No Data
No Data
Apollomics Signs Exclusive Development, Commercialization Deal for Vebreltinib in Asia
12 Health Care Stocks Moving In Monday's Pre-Market Session
Express News | Apollomics Inc - to Receive $10 Million Upfront, up to $50 Million in Milestones
Express News | Apollomics and Launxp Announce Development and Commercialization Agreement for Vebreltinib
US Stock Futures Rise as Investors Await Key Inflation Data
Express News | GlycoMimetics : On Feb 19, Received Notice From Apollomics (Hong Kong) Limited Terminating Collaboration and License Agreement